Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM).

Huishou Fan Bing Wang Lihui Shi Ni Pan Wenqiang Yan Jingyu Xu Lixin Gong Lingna Li Yuntong Liu Chenxing Du Jian Cui Guoqing Zhu Shuhui Deng Weiwei Sui Lian Xu Shuhua Yi Xiaojing Wei Dehui Zou Xie-Qun Chen Lugui Qiu Gang An

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)

EasyM is a highly sensitive and minimal invasive method of MRD monitoring in multiple myeloma; MS-MRD had significant predictive ability for survival outcomes.

Keyphrases

multiple myeloma
mass spectrometry
liquid chromatography
multiple sclerosis
ms ms
cancer therapy
capillary electrophoresis
high resolution
protein protein
amino acid
drug delivery